Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 5/20 | 0.51 |
| ▸ | NR1H3 | Q13133 | 5/20 | 0.51 |
| ▸ | RXRA | P19793 | 4/20 | 0.51 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.33 |
| ▸ | GNRHR | P30968 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.33 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.32 |
| ▸ | CMA1 | P23946 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12366458 | 0.92 | NR1H2 (0.43) | NR1H2NR1H3RXRAP2RX7MDM2 | |
| SCHEMBL12366501 | 0.90 | RXRA (0.41) | NR1H2NR1H3RXRAMDM2TRPV1 | |
| SCHEMBL12366328 | 0.90 | NR1H2 (0.41) | NR1H2NR1H3RXRAMDM2GNRHR | |
| SCHEMBL12366411 | 0.90 | RXRA (0.41) | NR1H2NR1H3RXRAMDM2GNRHR | |
| SCHEMBL12366310 | 0.89 | RXRA (0.59) | NR1H2NR1H3RXRAP2RX7GNRHR | |
| SCHEMBL12366407 | 0.89 | NR1H2 (0.40) | NR1H2NR1H3RXRAP2RX7MDM2 | |
| SCHEMBL12366466 | 0.87 | RXRA (0.38) | NR1H2NR1H3RXRAP2RX7MDM2 | |
| SCHEMBL12366323 | 0.87 | NR1H2 (0.39) | NR1H2NR1H3RXRAP2RX7MDM2 | |
| SCHEMBL12366330 | 0.87 | RGS4 (0.41) | NR1H2NR1H3RXRAMDM2 | |
| SCHEMBL12366418 | 0.86 | MAPT (0.42) | NR1H2NR1H3RXRAMDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7998986-B2 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS PATENT COMPANY LLC (US) | 2011-08-16 | — | — | US | disclosed |